Le Lézard
Classified in: Health, Science and technology

CenterWatch Announces: Powering an Effective Oversight Strategy with Clinical and Operational Insights Webinar on May 24, 2022


Clinical trial data dragging you down? Harness the power for better insights, compliance, outcomes with this free webinar.

FALLS CHURCH, Va., May 17, 2022 /PRNewswire-PRWeb/ -- Clinical trial professionals need to harness the power within their clinical trial data.

This free webinar will show them how to take control.

There's no doubt the volume, variety and velocity of data has never been greater, with the number of unique data sources now averaging 10 per clinical trial.

Jason Gubb, global clinical operations consultant and co-founder of EmergentTeams, and Sheila Rocchio, chief marketing officer of eClinical Solutions, will share how a single source of truth can power a more comprehensive oversight strategy.

The speakers will discuss that by automating data from numerous sources from the start, attendees can make it available for consumption by clinical teams for better decisionmaking. And ensure clinical teams collaborate more effectively to make certain of data quality, participant safety and operational excellence.

Using specific case examples, they'll explain how faster, and more reliable, data insights deliver value and improved experiences for cross-functional teams running trials, including:

This free webinar will show attendees how to use clinical trial data to their advantage.

Webinar Details:
Powering an Effective Oversight Strategy with Clinical and Operational Insights
A Free CenterWatch Webinar, Sponsored by eClinical Solutions
Tuesday, May 24, 2022, 11:00 a.m.-12:00 p.m. EDT
https://cwinfo.centerwatch.com/cw-web22524-powering-an-effective-oversight-strategy-with-clinical-and-operational-insights

Tuition:
Free

Easy Ways to Order:
Online: https://cwinfo.centerwatch.com/cw-web22524-powering-an-effective-oversight-strategy-with-clinical-and-operational-insights

By phone: 888.838.5578 or 703.538.7600

About CenterWatch:
Founded in 1994, CenterWatch is a trusted source and global destination for clinical trials information for both professionals and patients. CenterWatch provides proprietary data and information analysis on clinical trials through a variety of newsletters, books, databases, and information services used by pharmaceutical and biotechnology companies, CROs, SMOs, and investigative sites involved in the management and conduct of clinical trials. As a pioneer in publishing clinical trials information, CenterWatch was the first Internet site to publish detailed information about active clinical trials that could be accessed by patients and their advocates.

Media Contact

Michelle Butler, CenterWatch, 703-538-7665, [email protected]

 

SOURCE CenterWatch


These press releases may also interest you

at 02:48
Today, RaySearch Laboratories AB (publ)  publishes its Annual Report for the financial year 2023. The report is held available on RaySearch's website, under the section Investors.  This information is information that RaySearch Larboratiories AB...

at 02:43
Shareholders of Zinzino AB (publ) are hereby invited to the annual general meeting on Monday, May 27, 2024, at 1:30 PM at the company's premises at Hulda Mellgrens gata 5 in Gothenburg. Registration begins at 1:15 PM. The company aims to webcast the...

at 02:41
Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for the fiscal year 2023. The annual report is now available on the company's website. "Implantica had a very...

at 02:08
Revenue amounted to ?498.8m (?419.3m), an increase of 18.9% with an organic growth of 14.2%.Operating profit (EBIT) was ?19.0m (?10.7m), an increase of 78.0%, representing an operating margin of 3.8% (2.6%).Net profit amounted to ?6.5m (?2.1m), which...

at 02:00
Amwins Global Risks is delighted to announce Classic Cars and Cotswolds, an auction to raise money for the Matthew Wilson Multiple Myeloma Fund at Blood Cancer UK. The online auction opens today and features Ferraris, Aston Martins, a Rolls Royce, a...

at 01:35
Regulatory News: Sensorion (FR0012596468 ? ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces...



News published on and distributed by: